Company intelligence / Profile preview

InterVenn Biosciences

South San Francisco, California, United Statesintervenn.com ↗

Ownership: Private
Employees: ~191
Development stage: Commercial

Overview

InterVenn’s GlycoVision™ platform has demonstrated the ability to identify clinically relevant biomarkers from serum/plasma samples with high accuracy. Published results show early detection capabilities for advanced adenomas and colorectal carcinoma using serum glycoproteome profiling. The company has also shown that variable PD‑1 glycosylation modulates immune checkpoint inhibitor activity, supporting the clinical utility of its platform in immuno-oncology settings. Multiple programs are at various stages of clinical validation with promising early results reported at major conferences and in peer-reviewed journals

Therapeutic areas: OncologyInfectious Diseases
Modalities: Glycoproteomic diagnostics (liquid biopsy)biomarker discovery
Industry: Protein Biomarker Diagnostics

Drug pipeline

2 assets

GLORI

Commercial

Indications: Ovarian cancer

1 more asset in the full pipeline.

Request access →

Partnerships

Partners with physicians, researchers, biopharma organizations for biomarker discovery collaborations

Beyond the preview

Go deeper on InterVenn Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InterVenn Biosciences.

Explore the full profile